Health biotechnology in China: National, regional, and sectoral dimensions

Marcus Conlé

No 87/2010, Working Papers on East Asian Studies from University of Duisburg-Essen, Institute of East Asian Studies IN-EAST

Abstract: Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development.

Keywords: China; health biotechnology; innovation system; pharmaceutical (search for similar items in EconPapers)
Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/45003/1/640609481.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:udedao:872010

Access Statistics for this paper

More papers in Working Papers on East Asian Studies from University of Duisburg-Essen, Institute of East Asian Studies IN-EAST Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().